1. Home
  2. APLS
  3. APLS News

Latest Apellis Pharmaceuticals Inc. (APLS) News on July 26, 2024

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
APLS

Zacks

a day ago

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Apellis Pharmaceuticals to Host Conference Call on August 1, 2024, to Discuss Second Quarter 2024 Financial Results
APLS

GlobeNewswire

9 days ago

Apellis Pharmaceuticals to Host Conference Call on August 1, 2024, to Discuss Second Quarter 2024 Financial Results

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting
APLS

GlobeNewswire

18 days ago

Apellis Announces Five Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting

Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe
APLS

Zacks

21 days ago

Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe

Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug
APLS

Zacks

25 days ago

Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug

APLS

MT Newswires

a month ago

Sector Update: Health Care Stocks Edge Higher in Afternoon Trading

APLS

MT Newswires

a month ago

Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating

APLS

MT Newswires

a month ago

Update: Apellis Pharmaceuticals Shares Fall After Announcing Plan to Seek Re-Examination of Negative CHMP Opinion on Pegcetacoplan for Geographic Atrophy

APLS

MT Newswires

a month ago

Apellis Pharmaceuticals to Seek Re-Examination of Negative CHMP Opinion on Pegcetacoplan for Geographic Atrophy

APLS

MT Newswires

a month ago

--Wedbush Cuts Price Target on Apellis Pharmaceuticals to $40 From $50, Maintains Neutral Rating

Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
APLS

GlobeNewswire

a month ago

Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU

APLS

MT Newswires

a month ago

Apellis Pharmaceuticals Insider Sold Shares Worth $1,451,835, According to a Recent SEC Filing

Investors might be losing patience for Apellis Pharmaceuticals' (NASDAQ:APLS) increasing losses, as stock sheds 6.3% over the past week
APLS

Simply Wall St.

a month ago

Investors might be losing patience for Apellis Pharmaceuticals' (NASDAQ:APLS) increasing losses, as stock sheds 6.3% over the past week

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
APLS

GuruFocus.com

a month ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

APLS

Energy Global

a month ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
APLS

USA TODAY

a month ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
APLS

Business Wire

a month ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
APLS

Business Wire

a month ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips
APLS

GlobeNewswire

a month ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
APLS

Reuters

a month ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
APLS

GlobeNewswire

a month ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study
APLS

Zacks

a month ago

Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)
APLS

GlobeNewswire

2 months ago

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
APLS

Zacks

2 months ago

Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?

Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
APLS

GlobeNewswire

2 months ago

Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference

APLS

MT Newswires

2 months ago

Piper Sandler Starts Apellis Pharmaceuticals With Neutral Rating, $46 Price Target

Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data
APLS

Zacks

2 months ago

Apellis (APLS) Posts Upbeat One-Year Kidney Diseases Study Data

Apellis and Sobi report data from Phase II C3 glomerulopathy trial
APLS

Clinical Trials Arena

2 months ago

Apellis and Sobi report data from Phase II C3 glomerulopathy trial

APLS

MT Newswires

2 months ago

Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress
APLS

GlobeNewswire

2 months ago

Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress

APLS

MT Newswires

2 months ago

Wells Fargo Adjusts Price Target on Apellis Pharmaceuticals to $48 From $57, Maintains Equal-Weight Rating

APLS

MT Newswires

2 months ago

Apellis Pharmaceuticals Enters Into Senior Secured Credit Facility With Sixth Street

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street
APLS

GlobeNewswire

2 months ago

Apellis Pharmaceuticals Refinances Existing Debt with Up to $475 Million Non-Dilutive Credit Facility from Sixth Street

APLS

MT Newswires

3 months ago

Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing

Analysts Are Updating Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates After Its First-Quarter Results
APLS

Simply Wall St.

3 months ago

Analysts Are Updating Their Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Estimates After Its First-Quarter Results

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
APLS

Insider Monkey

3 months ago

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript

Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
APLS

Simply Wall St.

3 months ago

Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

APLS

GuruFocus.com

3 months ago

Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
APLS

Zacks

3 months ago

Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat

Apellis Pharmaceuticals (APLS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
APLS

Zacks

3 months ago

Apellis Pharmaceuticals (APLS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Tops Revenue Estimates
APLS

Zacks

3 months ago

Apellis Pharmaceuticals, Inc. (APLS) Reports Q1 Loss, Tops Revenue Estimates

APLS

MT Newswires

3 months ago

Apellis Pharmaceuticals Q1 Net Loss Narrows, Revenue Rises

Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
APLS

GlobeNewswire

3 months ago

Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results

Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
APLS

GlobeNewswire

3 months ago

Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference

Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
APLS

Zacks

3 months ago

Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for

Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
APLS

GlobeNewswire

3 months ago

Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
APLS

Zacks

3 months ago

Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know

APLS

MT Newswires

3 months ago

Apellis Pharmaceuticals Says EMA Moves Pegcetacoplan Application to Last Phase of Initial Assessment

Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
APLS

GlobeNewswire

3 months ago

Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
APLS

GlobeNewswire

3 months ago

Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
APLS

GlobeNewswire

4 months ago

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
APLS

GlobeNewswire

4 months ago

Apellis Pharmaceuticals to Host a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
APLS

Zacks

4 months ago

Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?

Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
APLS

GuruFocus.com

4 months ago

Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...

30 Biggest Biotechnology Companies in the World
APLS

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares
APLS

GuruFocus.com

4 months ago

Apellis Pharmaceuticals Inc (APLS) CTO Nur Nicholson Sells 11,220 Shares

Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares
APLS

GuruFocus.com

5 months ago

Apellis Pharmaceuticals Inc's Chief Scientific Officer Pascal Deschatelets Sells 69,107 Shares

Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor
APLS

GlobeNewswire

5 months ago

Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
APLS

GlobeNewswire

5 months ago

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript
APLS

Insider Monkey

5 months ago

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript

Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
APLS

Zacks

5 months ago

Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Earnings: What Key Metrics Have to Say
APLS

Zacks

5 months ago

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Earnings: What Key Metrics Have to Say

The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
APLS

Zacks

5 months ago

The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates
APLS

Zacks

5 months ago

Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Lags Revenue Estimates

Apellis Pharmaceuticals Inc (APLS) Reports Robust Revenue Growth in 2023
APLS

GuruFocus.com

5 months ago

Apellis Pharmaceuticals Inc (APLS) Reports Robust Revenue Growth in 2023

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
APLS

GlobeNewswire

5 months ago

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

5 Stocks to Buy That Are Poised to Beat on Earnings This Week
APLS

Zacks

5 months ago

5 Stocks to Buy That Are Poised to Beat on Earnings This Week

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
APLS

GlobeNewswire

5 months ago

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Why Apellis (APLS) Might Surprise This Earnings Season
APLS

Zacks

5 months ago

Why Apellis (APLS) Might Surprise This Earnings Season

Apellis Pharmaceuticals, Inc. (APLS) Upgraded to Buy: Here's What You Should Know
APLS

Zacks

5 months ago

Apellis Pharmaceuticals, Inc. (APLS) Upgraded to Buy: Here's What You Should Know

Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results
APLS

GlobeNewswire

5 months ago

Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?
APLS

Zacks

5 months ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?

Has Apellis Pharmaceuticals (APLS) Outpaced Other Medical Stocks This Year?
APLS

Zacks

5 months ago

Has Apellis Pharmaceuticals (APLS) Outpaced Other Medical Stocks This Year?

Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
APLS

Zacks

5 months ago

Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
APLS

GlobeNewswire

6 months ago

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

‘Riding High’: Evercore Suggests 2 Top Franchise Auto Dealer Stocks to Buy Now
APLS

TipRanks

6 months ago

‘Riding High’: Evercore Suggests 2 Top Franchise Auto Dealer Stocks to Buy Now

ITT (ITT) Reports Next Week: Wall Street Expects Earnings Growth
APLS

Zacks

6 months ago

ITT (ITT) Reports Next Week: Wall Street Expects Earnings Growth

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
APLS

Zacks

6 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Lithia & Driveway Enters into a Strategic Partnership with Pinewood Technologies and Completes Acquisition for Pendragon PLCs Fleet Management and UK Motor Divisions
APLS

PR Newswire

6 months ago

Lithia & Driveway Enters into a Strategic Partnership with Pinewood Technologies and Completes Acquisition for Pendragon PLCs Fleet Management and UK Motor Divisions

S&P 500 Stock Gets $14 Billion Takeover Bid, Rockets 15% Early. Rival In Buy Zone.
APLS

Investor's Business Daily

6 months ago

S&P 500 Stock Gets $14 Billion Takeover Bid, Rockets 15% Early. Rival In Buy Zone.

Robert Half Named a Fortune® World's Most Admired Company™ for 27th Consecutive Year
APLS

PR Newswire

6 months ago

Robert Half Named a Fortune® World's Most Admired Company™ for 27th Consecutive Year

Robert Half's (RHI) Q4 Earnings Beat Estimates, Decline Y/Y
APLS

Zacks

6 months ago

Robert Half's (RHI) Q4 Earnings Beat Estimates, Decline Y/Y

Woodward, Inc. (NASDAQ:WWD) Q1 2024 Earnings Call Transcript
APLS

Insider Monkey

6 months ago

Woodward, Inc. (NASDAQ:WWD) Q1 2024 Earnings Call Transcript

FLOOR & DECOR REVEALS TOP FLOORING AND TILE TRENDS OF 2024
APLS

PR Newswire

6 months ago

FLOOR & DECOR REVEALS TOP FLOORING AND TILE TRENDS OF 2024

While Cytokinetics (NASDAQ:CYTK) shareholders have made 999% in 5 years, increasing losses might now be front of mind as stock sheds 4.4% this week
APLS

Simply Wall St.

6 months ago

While Cytokinetics (NASDAQ:CYTK) shareholders have made 999% in 5 years, increasing losses might now be front of mind as stock sheds 4.4% this week

Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last?
APLS

Zacks

6 months ago

Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last?

APLS

GlobeNewswire

6 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
APLS

GlobeNewswire

6 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

McGrath RentCorp Stock Jumps on Deal to Be Bought for $3.8 Billion by WillScot Mobile
APLS

Barrons.com

6 months ago

McGrath RentCorp Stock Jumps on Deal to Be Bought for $3.8 Billion by WillScot Mobile

Portable-Building Companies Strike $3 Billion Deal
APLS

The Wall Street Journal

6 months ago

Portable-Building Companies Strike $3 Billion Deal

Apellis (APLS) Down on Negative CHMP Opinion for Pegcetacoplan
APLS

Zacks

6 months ago

Apellis (APLS) Down on Negative CHMP Opinion for Pegcetacoplan

Interactive Brokers: A Brokerage Powerhouse With Upside Potential
APLS

GuruFocus.com

6 months ago

Interactive Brokers: A Brokerage Powerhouse With Upside Potential

WillScot Mobile Mini to Acquire McGrath RentCorp for $3.8 Billion, Enhancing Its Position as the North American Leader in Turnkey Space Solutions
APLS

GlobeNewswire

6 months ago

WillScot Mobile Mini to Acquire McGrath RentCorp for $3.8 Billion, Enhancing Its Position as the North American Leader in Turnkey Space Solutions

Interactive Brokers Stock Near All-Time High; Rating Upgraded
APLS

Investor's Business Daily

6 months ago

Interactive Brokers Stock Near All-Time High; Rating Upgraded

Interactive Brokers Group Inc CIO Thomas Frank Sells 92,959 Shares
APLS

GuruFocus.com

6 months ago

Interactive Brokers Group Inc CIO Thomas Frank Sells 92,959 Shares

Bread Financial (BFH) Q4 Earnings Beat, Revenues Fall Y/Y
APLS

Zacks

6 months ago

Bread Financial (BFH) Q4 Earnings Beat, Revenues Fall Y/Y

WestRock Announces Quarterly Dividend of $0.3025 Per Share
APLS

Business Wire

6 months ago

WestRock Announces Quarterly Dividend of $0.3025 Per Share

Allison (ALSN) Partners SANY for Mining Transmission Solutions
APLS

Zacks

6 months ago

Allison (ALSN) Partners SANY for Mining Transmission Solutions

Costco (COST) Thrives on Business Model and Pricing Power
APLS

Zacks

6 months ago

Costco (COST) Thrives on Business Model and Pricing Power

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application
APLS

GlobeNewswire

6 months ago

Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and Plans to Seek Re-Examination of Application

Share on Social Networks: